Kai-Keen Shiu

Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial

Thierry André, Mayur M. Amonkar, Josephine M. Norquist et al. · The Lancet Oncology · 2021 · 220 citations · Full text

Medicine, Oncology, Chemotherapy +11

Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts

Michele Bortolomeazzi, Mohamed Reda Keddar, Lucia Montorsi et al. · Gastroenterology · 2021 · 147 citations · Full text

Medicine, Immunology, Oncology +17

Functional characterization of the 19q12 amplicon in grade III breast cancers

Rachael Natrajan, Alan Mackay, Paul M Wilkerson et al. · Breast Cancer Research · 2012 · 94 citations · Full text

Life Sciences, Genetics, Oncology +11

Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): an open-label, randomised, phase 2 study

Alwin Krämer, Tilmann Bochtler, Chantal Pauli et al. · The Lancet · 2024 · 75 citations · Full text

Medicine, Clinical Sciences, Oncology +8

COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort study

Valerie Crolley, Daire Hanna, Nalinie Joharatnam‐Hogan et al. · Therapeutic Advances in Medical Oncology · 2020 · 20 citations · Full text

Medicine, Oncology, Cancer Epidemiology +9